Reducing the burden of malaria in pregnancy by preventive strategies

Lancet Infectious Diseases

Volumn 7, Issue 2, 2007, Pages 126-135

  Menéndez, Clara ^a,b   D'Alessandro, Umberto ^c   ter Kuile, Feiko O ^d,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministérioda Saúde   (Mozambique)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; COTRIMOXAZOLE; DIHYDROARTEMISININ; FANSIDAR; INSECTICIDE; MALARIA VACCINE; MALOPRIM; MEFLOQUINE; PIPERAQUINE; PROTEINASE INHIBITOR; RETINOL;

AFRICA; ANEMIA; ASIA; BED NET; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DIZZINESS; DRUG MEGADOSE; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE COST; HEALTH PROGRAM; HEMOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERMITTENT PREVENTIVE TREATMENT IN PREGNANCY; MALARIA; MALARIA CONTROL; MENTAL DISEASE; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SOUTH AND CENTRAL AMERICA; STILLBIRTH; VECTOR CONTROL;

ANIMALS; ANTIMALARIALS; BEDDING AND LINENS; CHEMOPREVENTION; FEMALE; HUMANS; INFANT, NEWBORN; INSECTICIDES; MALARIA, FALCIPARUM; MOSQUITO CONTROL; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 33846317129     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70024-5     Document Type: Review

References (101)

1. WHO. A strategic framework for malaria prevention and control during pregnancy in the African region (2004), World Health Organization, Geneva AFR/MAL.
2. Steketee R., Nahlen B., Parise M., and Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 64 suppl 1-2 (2001) 28-35
3. Singh N., Mehra R., and Srivastava N. Malaria during pregnancy and infancy, in an area of intense malaria transmission in central India. Ann Trop Med Parasitol 95 (2001) 19-29
4. Nosten F., McGready R., Simpson J., et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet 354 (1999) 546-549
5. Rodriguez-Morales A., Sanchez E., Vargas M., et al. Pregnancy outcomes associated with Plasmodium vivax malaria in Northeastern Venezuela. Am J Trop Med Hyg 74 (2006) 755-757
6. ter Kuile F., Parise M., Verhoeff F., et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71 suppl 2 (2004) 41-54
7. Nosten F., McGready R., and Mutabingwa T. Case management of malaria in pregnancy. Lancet Infect Dis 7 (2007) 118-125
8. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2 (2004) CD000363
9. Browne E., Maude G., and Binka F. The impact of insecticide-treated bednets on malaria and anaemia in pregnancy in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health 6 (2001) 667-676
10. Shulman C., Dorman E., Talisuna A., et al. A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coast. Trop Med Int Health 3 (1998) 197-204
11. D'Alessandro U., Langerock P., Bennett S., Francis N., Cham K., and Greenwood B. The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans R Soc Trop Med Hyg 90 (1996) 487-492
12. Gamble C., Ekwaru J., and ter Kuile F. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev 2 (2006) CD003755
13. ter Kuile F., Terlouw D., Phillips-Howard P., et al. Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 68 suppl 4 (2003) 50-60
14. Njagi J., Magnussen P., Estambale B., Ouma J., and Mugo B. Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. Trans R Soc Trop Med Hyg 97 (2003) 277-282
15. Crawley J., Hill J., Yartey J., et al. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis 7 (2007) 145-155
16. Dolan G., ter Kuile F., Jacoutot V., et al. Bed nets for the prevention of malaria and anaemia in pregnancy. Trans R Soc Trop Med Hyg 87 (1993) 620-626
17. WHO. Global Malaria Programme indoor residual spraying. Use of indoor residual spraying for scaling up global malaria control and elimination. WHO Position Statement (2006), World Health Organization, Geneva WHO/HTM/MAL/2006.1112.
18. Communicable Disease Control, and Prevention and Eradication WHO Pesticide Evaluation Scheme (WHOPES) and Protection of the Human Environment Programme on Chemical Safety (PCS). Safety of pyrethroids for public health use. WHO/CDS/WHOPES/GCDPP/2005.10. WHO/PCS/RA/2005.1 (2005). http://whqlibdoc.who.int/hq/2005/WHO_CDS_WHOPES_GCDPP_2005.10.pdf (accessed Dec 4, 2006).
19. Lindsay S., Ewald J., Samung Y., Apiwathnasorn C., and Nosten F. Thanaka (Limonia acidissima) and DEET (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women. Med Vet Entomol 12 (1998) 295-301
20. McGready R., Hamilton K., Simpson J., et al. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg 65 (2001) 285-289
21. McGready R., Simpson J., Htway M., White N., Nosten F., and Lindsay S. A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 95 (2001) 137-138
22. Cot M., Le Hesran J., Miailhes P., Esveld M., Etya'ale D., and Breart G. Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: results of a randomized trial in Cameroon. Am J Trop Med Hyg 53 (1995) 581-585
23. Cot M., Le Hesran J., Miailhes P., et al. Effect of chloroquine prophylaxis during pregnancy on maternal haematocrit. Ann Trop Med Parasitol 92 (1998) 37-43
24. Cot M., Roisin A., Barro D., et al. Effect of chloroquine prophylaxis during pregnancy on birth weight: results of a randomized trial. Am J Trop Med Hyg 46 (1992) 21-27
25. Rukaria-Kaumbutho R., Ojwang S., and Oyieke J. Resistance to chloroquine therapy in pregnant women with malaria parasitemia. Int J Gynaecol Obstet 53 (1996) 235-241
26. Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today 11 (1995) 178-183
27. Greenwood A., Menendez C., Alonso P., et al. Can malaria chemoprophylaxis be restricted to first pregnancies?. Trans R Soc Trop Med Hyg 88 (1994) 681-682
28. Schultz L., Steketee R., Macheso A., Kazembe P., Chitsulo L., and Wirima J. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51 (1994) 515-522
29. Parise M., Ayisi J., Nahlen B., et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59 (1998) 813-822
30. Verhoeff F., Brabin B., Chimsuku L., Kazembe P., Russell W., and Broadhead R. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92 (1998) 141-150
31. Shulman C., Dorman E., Cutts F., et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353 (1999) 632-636
32. White N. Intermittent presumptive treatment for malaria. PLoS Med 2 (2005) e3
33. McCollum A., Poe A., Hamel M., et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 194 (2006) 189-197
34. Hastings M., Bates S., Blackstone E., Monks S., Mutabingwa T., and Sibley C. Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. Trans R Soc Trop Med Hyg 96 (2002) 674-676
35. Alker A., Mwapasa V., Purfield A., et al. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob Agents Chemother 49 (2005) 3919-3921
36. Farnert A., Tengstam K., Palme I., et al. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis. Am J Trop Med Hyg 66 (2002) 487-491
37. Staedke S., Sendagire H., Lamola S., Kamya M., Dorsey G., and Rosenthal P. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop Med Int Health 9 (2004) 624-629
38. Kalanda G., Hill J., Verhoeff F., and Brabin B. Comparative efficacy of chloroquine and sulphadoxine-pyrimethamine in pregnant women and children: a meta-analysis. Trop Med Int Health 11 (2006) 569-577
39. Tagbor H., Bruce J., Browne E., Randal A., Greenwood B., and Chandramohan D. Efficacy, safety, and tolerability of amodiaquine and sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 368 (2006) 1349-1356
40. Filler S., Kazembe P., Thigpen M., et al. Randomized trial of 2-dose versus monthly sulfadoxine/pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis 194 (2006) 286-293
41. Challis K., Osman N., Cotiro M., Nordahl G., Dgedge M., and Bergstrom S. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health 9 (2004) 1066-1073
42. ter Kuile F., van Eijk A., and Filler S. Can the treatment response in children with symptomatic malaria be used to guide policy for case management and intermittent preventive treatment of malaria in pregnancy? A review of published and unpublished literature (2005), World Health Organization, Regional Office for Africa, Harare, Zimbabwe
43. Rogerson S., Chaluluka E., Kanjala M., Mkundika P., Mhango C., and Molyneux M. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg 94 (2000) 549-553
44. Greenwood B., Greenwood A., Snow R., Byass P., Bennett S., and Hatib-N'Jie A. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 83 (1989) 589-594
45. Menendez C., Ordi J., Ismail M., et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis 181 (2000) 1740-1745
46. Centers for Disease Control and Prevention. Travelers' health. Information for the public: preventing malaria in the pregnant woman. http://www.cdc.gov/travel/mal_preg_pub.htm (accessed Dec 4, 2006).
47. Newman R., Parise M., Slutsker L., Nahlen B., and Steketee R. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health 8 (2003) 488-506
48. Nosten F., Vincenti M., Simpson J., et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 28 (1999) 808-815
49. Steketee R., Wirima J., Slutsker L., et al. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. Am J Trop Med Hyg 55 (1996) 24-32
50. Nosten F., ter Kuile F., Maelankiri L., et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis 169 (1994) 595-603
51. ter Kuile F., Nosten F., Thieren M., et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis 166 (1992) 1393-1400
52. ter Kuile F., Nosten F., Luxemburger C., et al. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ 73 (1995) 631-642
53. Thomas F., Erhart A., and D'Alessandro U. Can amodiaquine be used safely during pregnancy?. Lancet Infect Dis 4 (2004) 235-239
54. Kublin J., Cortese J., Njunju E., et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187 (2003) 1870-1875
55. Kayentao K., Kodio M., Newman R., et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 191 (2005) 109-116
56. Villegas L, McGready R, Htway M, et al. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop Med Int Health (in press).
57. McGready R., Cho T., Keo N., et al. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin Infect Dis 33 (2001) 2009-2016
58. Clark R., White T., Clode A., Gaunt I., Winstanley P., and Ward S. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 71 (2004) 380-394
59. Ward S., Sevene E., Hastings I., Nosten F., and McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis 7 (2007) 136-144
60. Steketee R., Wirima J., Bloland P., et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55 suppl 1 (1996) 42-49
61. Wolfe E., Parise M., Haddix A., et al. Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight. Am J Trop Med Hyg 64 (2001) 178-186
62. WHO. WHO expert consultation on cotrimoxazole prophylaxis in HIV infection (2006), World Health Organization, Geneva. http://www.who.int/hiv/pub/meetingreports/ctx/en/index.html (accessed Dec 4, 2006).
63. Gimnig J., Macarthur J., M'bang'ombe M., et al. Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. Am J Trop Med Hyg 74 (2006) 738-743
64. Mehaffey P., Barrett M., Putnam S., and Jones R. Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria. Diagn Microbiol Infect Dis 23 (1995) 11-13
65. Feikin D., Dowell S., Nwanyanwu O., et al. Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine. J Infect Dis 181 (2000) 1501-1505
66. Daramola O., Alonso P., O'Dempsey T., Twumasi P., McArdle T., and Greenwood B. Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. Trans R Soc Trop Med Hyg 85 (1991) 345-348
67. Thera M., Sehdev P., Coulibaly D., et al. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 192 (2005) 1823-1829
68. Anglaret X., Messou E., Ouassa T., et al. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Cote d'Ivoire. AIDS 17 (2003) 575-584
69. Mermin J., Lule J., Ekwaru J., et al. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS 19 (2005) 1035-1042
70. Mermin J., Lule J., Ekwaru J., and Pitter C. Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa?. AIDS 19 (2005) 845-846
71. Owen A., Janneh O., Hartkoorn R., et al. In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine. J Pharmacol Exp Ther 314 (2005) 1202-1209
72. Serghides L., Nathoo S., Walmsley S., and Kain K. CD36 deficiency induced by antiretroviral therapy. AIDS 16 (2002) 353-358
73. Nathoo S., Serghides L., and Kain K. Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. Lancet 362 (2003) 1039-1041
74. Rogerson S. HIV-1, antiretroviral therapy, and malaria. Lancet 362 (2003) 1008-1009
75. Skinner-Adams T., McCarthy J., Gardiner D., Hilton P., and Andrews K. Antiretrovirals as antimalarial agents. J Infect Dis 190 (2004) 1998-2000
76. Rogerson S., and Menendez C. Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Rev Anti Infect Ther 4 (2006) 687-702
77. Garner P., and Gulmezoglu A. Prevention versus treatment for malaria in pregnant women. Cochrane Database Syst Rev 2 (2000) CD000169
78. Rogerson S., van den Broek N., Chaluluka E., Qongwane C., Mhango C., and Molyneux M. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 62 (2000) 335-340
79. Saute F., Menendez C., Mayor A., et al. Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health 7 (2002) 19-28
80. Zhou A., Megnekou R., Leke R., et al. Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women. Am J Trop Med Hyg 67 (2002) 566-570
81. Cornet M., Le Hesran J., Fievet N., et al. Prevalence of and risk factors for anemia in young children in southern Cameroon. Am J Trop Med Hyg 58 (1998) 606-611
82. Mutabingwa T., Bolla M., Li J., et al. Maternal malaria and gravidity interact to modify infant susceptibility to Malaria. PloS Med 2 (2005) e407
83. Reed S., Wirima J., and Steketee R. Risk factors for anemia in young children in rural Malawi. Am J Trop Med Hyg 51 (1994) 170-174
84. van Eijk A., Ayisi J., ter Kuile F., et al. Malaria and human immunodeficiency virus infection as risk factors for anemia in infants in Kisumu, western Kenya. Am J Trop Med Hyg 67 (2002) 44-53
85. Nosten F., Rogerson S., Beeson J., McGready R., Mutabingwa T., and Brabin B. Malaria in pregnancy and the endemicity spectrum: what can we learn?. Trends Parasitol 20 (2004) 425-432
86. van Hensbroek M., Morris-Jones S., Meisner S., et al. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 89 (1995) 672-676
87. Mbaye A., Richardson K., Balajo B., et al. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Trop Med Int Health 11 (2006) 992-1002
88. Ouma P., Parise M., Hamel M., et al. A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine. PLoS Clin Trials 1 (2006) e28
89. Sazawal S., Black R., Ramsan M., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367 (2006) 133-143
90. Oppenheimer S. Iron and its relation to immunity and infectious disease. J Nutr 131 suppl (2001) 616S-633S
91. Gera T., and Sachdev H. Effect of iron supplementation on incidence of infectious illness in children: systematic review. BMJ 325 (2002) 1142
92. Menendez C., Kahigwa E., Hirt R., et al. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350 (1997) 844-850
93. Fleming A., Ghatoura G., Harrison K., Briggs N., and Dunn D. The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. Ann Trop Med Parasitol 80 (1986) 211-233
94. Menendez C., Todd J., Alonso P., et al. The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg 88 (1994) 590-593
95. Menendez C., Todd J., Alonso P., et al. The response to iron supplementation of pregnant women with the haemoglobin genotype AA or AS. Trans R Soc Trop Med Hyg 89 (1995) 289-292
96. WHO/UNICEF/IVACG/HKI. Vitamin A supplements. A guide to their use in the treatment and prevention of Vitamin A deficiency. 3rd edn. (2001), World Health Organization, Geneva
97. Shankar A., Genton B., Semba R., et al. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet 354 (1999) 203-209
98. Cox S., Staalsoe T., Arthur P., et al. Maternal vitamin A supplementation and immunity to malaria in pregnancy in Ghanaian primigravids. Trop Med Int Health 10 (2005) 286-297
99. Alonso P., Sacarlal J., Aponte J., et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 (2004) 1411-1420
100. Rogerson S., Hviid L., Duffy P., Leke R., and Taylor D. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 7 (2007) 105-117
101. Worrall E., Morel C., Yeung S., et al. The economics of malaria in pregnancy-a review of the evidence and research priorities. Lancet Infect Dis 7 (2007) 156-168